Financhill
Sell
35

REFI Quote, Financials, Valuation and Earnings

Last price:
$15.98
Seasonality move :
-3.38%
Day range:
$15.69 - $16.03
52-week range:
$14.82 - $17.65
Dividend yield:
11.77%
P/E ratio:
7.99x
P/S ratio:
5.52x
P/B ratio:
1.06x
Volume:
244.3K
Avg. volume:
99.6K
1-year change:
-2.65%
Market cap:
$313.7M
Revenue:
$57.3M
EPS (TTM):
$2.00
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- -- -- $48.9M $57.3M
Revenue Growth (YoY) -- -- -- -- 17.34%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $4M $6.7M
Other Inc / (Exp) -- -- -- -- $180.4K
Operating Expenses -- -- -- $4M $6.7M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- $32.3M $38.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- $32.3M $38.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $32.3M $38.7M
 
Basic EPS (Cont. Ops) -- -- -- $1.83 $2.14
Diluted EPS (Cont. Ops) -- -- -- $1.82 $2.11
Weighted Average Basic Share -- -- -- $17.7M $18.1M
Weighted Average Diluted Share -- -- -- $17.7M $18.3M
 
EBITDA -- -- -- -- --
EBIT -- -- -- $34.9M $44.5M
 
Revenue (Reported) -- -- -- $48.9M $57.3M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- $34.9M $44.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $4.1M $12.9M $13.8M $14.5M
Revenue Growth (YoY) -- -- 214.22% 6.85% 4.63%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $13.5K $2.5M $1.8M $2.1M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- $13.5K $2.5M $1.8M $2.1M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- $4.1M $9.8M $10M $11.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- $9.8M $10M $11.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- $4.1M $9.8M $10M $11.2M
 
Basic EPS (Cont. Ops) -- $0.23 $0.55 $0.55 $0.57
Diluted EPS (Cont. Ops) -- $0.23 $0.55 $0.54 $0.56
Weighted Average Basic Share -- $17.4M $17.7M $18.2M $19.6M
Weighted Average Diluted Share -- $17.4M $17.8M $18.6M $20.1M
 
EBITDA -- -- -- -- --
EBIT -- $4.1M $10.6M $11.4M $13M
 
Revenue (Reported) -- $4.1M $12.9M $13.8M $14.5M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- $4.1M $10.6M $11.4M $13M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- $39.8M $57.2M $55.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- $7.1M $2.7M $8.1M
Other Inc / (Exp) -- -- -- -- $177.2K
Operating Expenses -- -- $7.1M $2.7M $8.1M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- $29.4M $36.6M $38.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- $36.6M $38.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- $29.4M $36.6M $38.5M
 
Basic EPS (Cont. Ops) -- -- $1.66 $2.04 $2.04
Diluted EPS (Cont. Ops) -- -- $1.66 $2.02 $2.00
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- $30.8M $41.9M $46M
 
Revenue (Reported) -- -- $39.8M $57.2M $55.8M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- $30.8M $41.9M $46M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $5.3M $34.1M $42.4M $40.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $13.5K $6M $4.7M $6.1M
Other Inc / (Exp) -- -- -- -- -$3.2K
Operating Expenses -- $13.5K $6M $4.7M $6.1M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- $5.1M $25M $29.3M $29.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- $25M $29.3M $29.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- $5.1M $25M $29.3M $29.1M
 
Basic EPS (Cont. Ops) -- $0.29 $1.41 $1.63 $1.52
Diluted EPS (Cont. Ops) -- $0.29 $1.41 $1.61 $1.49
Weighted Average Basic Share -- $34.9M $53M $54.1M $57.3M
Weighted Average Diluted Share -- $34.9M $53.2M $54.8M $58.6M
 
EBITDA -- -- -- -- --
EBIT -- $5.2M $26.4M $33.4M $34.9M
 
Revenue (Reported) -- $5.3M $34.1M $42.4M $40.9M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- $5.2M $26.4M $33.4M $34.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents -- -- $80.2M $5.7M $7.9M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- $197.7K $1.2M $1M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -- -- $81.3M $6.9M $9M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- $842.3K
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- $278.2M $343.3M $359.2M
 
Accounts Payable -- -- $212.9K -- --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- $7.5M $76.3M $85.2M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- $14.1M $79.2M $87.4M
 
Common Stock -- -- $173.6K $176.9K $182K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- $264.1M $264M $271.9M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- $264.1M $264M $271.9M
 
Total Liabilities and Equity -- -- $278.2M $343.3M $359.2M
Cash and Short Terms -- -- $80.2M $5.7M $7.9M
Total Debt -- -- -- $58M $66M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- $8.7M $9.3M $8.7M $6.8M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- $517K $727.3K $2.2M $484.4K
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -- $9.3M $10.9M $15.2M $8.7M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- $3.5M --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- $136.9M $340.5M $352.3M $365.9M
 
Accounts Payable -- $159.1K $716.5K $1.2M --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- $1.6M $64.7M $76M $66.5M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- $8.2M $70.3M $76.5M $70.4M
 
Common Stock -- $80.4K $176.6K $181.8K $196.4K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- $128.7M $270.2M $275.8M $295.5M
 
Total Liabilities and Equity -- $136.9M $340.5M $352.3M $365.9M
Cash and Short Terms -- $8.7M $9.3M $8.7M $6.8M
Total Debt -- -- $53M $63M $54M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- -- -- $32.3M $38.7M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- $435.6K $1.5M
Change in Accounts Receivable -- -- -- -$1.1M $41.7K
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- $17M $28.4M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$125.2M -$1.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -$28.2M -$39.1M
Special Dividend Paid
Long-Term Debt Issued -- -- -- $58M $82M
Long-Term Debt Repaid -- -- -- -- -$74M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$625.5K -$396.9K
Cash From Financing -- -- -- $33.7M -$24.3M
 
Beginning Cash (CF) -- -- -- $80.2M $5.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$74.5M $2.2M
Ending Cash (CF) -- -- -- $5.7M $7.9M
 
Levered Free Cash Flow -- -- -- $17M $28.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- $9.8M $10M $11.2M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- $84.9K $540.4K $845.5K
Change in Accounts Receivable -- -- $221.7K -$4.3M -$13.2K
Change in Inventories -- -- -- -- --
Cash From Operations -- -- $5M $1000K $8.2M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -$2M -$21.7M $23.5M
 
Dividends Paid (Ex Special Dividend) -- -- -$8.3M -$8.6M -$9.3M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $8M $30M $29.5M
Long-Term Debt Repaid -- -- -- -$10M -$52.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$55.5K -$89.7K
Cash From Financing -- -- -$299.2K $11.4M -$32.1M
 
Beginning Cash (CF) -- -- $6.6M $18M $7.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- $2.7M -$9.3M -$310.5K
Ending Cash (CF) -- -- $9.3M $8.7M $6.8M
 
Levered Free Cash Flow -- -- $5M $1M $8.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- $36.6M $38.5M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- $328.4K $1M $2.8M
Change in Accounts Receivable -- -- -- -$4.9M $3.6M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- $17.5M $36.8M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- $4.3M -$8.8M
 
Dividends Paid (Ex Special Dividend) -- -- -$19.9M -$38.9M -$40.9M
Special Dividend Paid
Long-Term Debt Issued -- -- -- $69M $91.5M
Long-Term Debt Repaid -- -- -- -$59M -$100.5M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$821.2K -$869.7K
Cash From Financing -- -- -- -$22.5M -$30M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$629.4K -$1.9M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- $17.5M $36.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- $25M $29.3M $29.1M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- $328.4K $942.6K $2.2M
Change in Accounts Receivable -- -- -$702.2K -$4.5M -$902.7K
Change in Inventories -- -- -- -- --
Cash From Operations -- -- $12.4M $12.9M $21.3M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -$120.7M $8.8M $2M
 
Dividends Paid (Ex Special Dividend) -- -- -$19.9M -$30.6M -$32.4M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $53M $64M $73.5M
Long-Term Debt Repaid -- -- -- -$59M -$85.5M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$201.2K -$396.9K -$869.7K
Cash From Financing -- -- $37.4M -$18.7M -$24.4M
 
Beginning Cash (CF) -- -- $92.9M $28.4M $21.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -$70.9M $3M -$1.1M
Ending Cash (CF) -- -- $22M $31.4M $20.7M
 
Levered Free Cash Flow -- -- $12.4M $12.9M $21.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock